Pierre Van Damme Selected Research

Pierre Van Damme Research Topics

Disease

33	Whooping Cough (Pertussis) 12/2023 - 03/2003
29	Infections 03/2024 - 06/2004
28	Hepatitis B 01/2022 - 06/2002
25	Tetanus 12/2023 - 03/2003
25	Diphtheria 12/2023 - 03/2003
20	Hepatitis A (Hepatitis, Infectious) 09/2023 - 06/2002
13	Human Influenza (Influenza) 10/2023 - 03/2003
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 12/2008
12	Poliomyelitis (Polio) 01/2023 - 07/2005
11	COVID-19 03/2024 - 12/2020
9	Measles 01/2023 - 02/2003
9	Communicable Diseases (Infectious Diseases) 01/2022 - 08/2005
6	Hepatitis 10/2023 - 03/2003
6	Mumps 01/2021 - 11/2005
6	Rubella (German Measles) 01/2021 - 11/2005
6	Neoplasms (Cancer) 01/2019 - 11/2012
5	Papillomavirus Infections 01/2019 - 11/2012
4	Herpes Zoster 04/2024 - 01/2003
4	Pain (Aches) 01/2021 - 01/2014
4	Multiple Sclerosis 01/2016 - 11/2005
4	Gastroenteritis 08/2012 - 01/2006
3	Vaccine-Preventable Diseases 12/2023 - 02/2003
3	Liver Diseases (Liver Disease) 01/2023 - 06/2002
3	Headache (Headaches) 01/2021 - 04/2010
3	Malaria 11/2019 - 01/2004
2	Ebola Hemorrhagic Fever 03/2024 - 01/2023
2	Breakthrough Infections 11/2022 - 01/2013
2	Typhoid Fever (Typhoid) 11/2019 - 11/2003
2	Warts (Wart) 01/2019 - 01/2016
2	Meningitis 01/2019 - 08/2008
2	Intussusception 06/2015 - 01/2006
2	Hepatitis E 10/2012 - 01/2010
2	Chickenpox 05/2005 - 01/2003
1	Hepatocellular Carcinoma (Hepatoma) 03/2024
1	Virus Diseases (Viral Diseases) 10/2023
1	Reinfection 09/2023
1	Lassa Fever (Fever, Lassa) 01/2023
1	Chronic recurrent multifocal osteomyelitis 10/2022
1	Rheumatic Diseases (Rheumatism) 10/2022
1	Fatigue 01/2021
1	Myalgia 01/2021
1	Pneumococcal Infections 01/2020
1	Japanese Encephalitis 11/2019

Drug/Important Bio-Agent (IBA)

113	VaccinesIBA 03/2024 - 06/2002
28	AntibodiesIBA 09/2023 - 06/2002
18	AntigensIBA 01/2023 - 06/2002
12	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2021 - 07/2002
11	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2024 - 01/2007
6	Papillomavirus Vaccines (HPV Vaccines)IBA 12/2023 - 10/2011
5	Pertussis ToxinIBA 01/2021 - 06/2003
5	pertactin FDA Link 01/2017 - 06/2003
5	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 10/2015 - 11/2003
4	Immunoglobulin G (IgG)IBA 09/2023 - 08/2015
4	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2021 - 10/2008
4	Combined VaccinesIBA 11/2020 - 06/2004
4	Pertussis VaccineIBA 11/2020 - 01/2016
4	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 10/2020 - 11/2007
4	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018 - 01/2009
4	RotaTeqIBA 06/2015 - 12/2009
4	Pentetic Acid (DTPA)FDA LinkGeneric 08/2011 - 03/2003
3	EpitopesIBA 04/2024 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2017
3	Hepatitis A AntibodiesIBA 09/2023 - 11/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
3	Rotavirus VaccinesIBA 08/2012 - 03/2009
3	twinrixIBA 03/2011 - 06/2004
2	Antiviral Agents (Antivirals)IBA 10/2023 - 05/2019
2	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2022
2	Poliovirus VaccinesIBA 01/2023 - 11/2007
2	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 01/2021 - 10/2019
2	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2021 - 03/2003
2	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 10/2020 - 10/2017
2	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 10/2020 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2018
2	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 06/2003
2	BoostrixIBA 01/2016 - 01/2004
2	RIX4414 vaccineIBA 06/2015 - 12/2009
2	Engerix-BIBA 04/2007 - 06/2006
2	Thimerosal (Thiomersal)IBA 04/2007 - 11/2005
1	Glycoproteins (Glycoprotein)IBA 04/2024
1	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 03/2024
1	HLA-DR Antigens (HLA-DR)IBA 02/2024
1	N 30IBA 02/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2023
1	Conjugate VaccinesIBA 02/2023
1	NucleoproteinsIBA 12/2022
1	Recombinant ProteinsIBA 12/2022
1	COVID-19 VaccinesIBA 11/2022
1	CytokinesIBA 10/2022
1	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Inactivated VaccinesIBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020

Therapy/Procedure

2	Personal Protective Equipment 01/2022 - 01/2021
2	Therapeutics 01/2019 - 01/2015
2	Injections 01/2014 - 01/2009
1	Intramuscular Injections 03/2024
1	Aftercare (After-Treatment) 08/2021